403 related articles for article (PubMed ID: 23918355)
1. Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.
Lee MO; Moon SH; Jeong HC; Yi JY; Lee TH; Shim SH; Rhee YH; Lee SH; Oh SJ; Lee MY; Han MJ; Cho YS; Chung HM; Kim KS; Cha HJ
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):E3281-90. PubMed ID: 23918355
[TBL] [Abstract][Full Text] [Related]
2. Intact wound repair activity of human mesenchymal stem cells after YM155 mediated selective ablation of undifferentiated human embryonic stem cells.
Kim KT; Jeong HC; Kim CY; Kim EY; Heo SH; Cho SJ; Hong KS; Cha HJ
J Dermatol Sci; 2017 May; 86(2):123-131. PubMed ID: 28185769
[TBL] [Abstract][Full Text] [Related]
3. Hepatic population derived from human pluripotent stem cells is effectively increased by selective removal of undifferentiated stem cells using YM155.
Kang SJ; Park YI; Hwang SR; Yi H; Tham N; Ku HO; Song JY; Kang HG
Stem Cell Res Ther; 2017 Apr; 8(1):78. PubMed ID: 28412976
[TBL] [Abstract][Full Text] [Related]
4. Preventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.
Bedel A; Beliveau F; Lamrissi-Garcia I; Rousseau B; Moranvillier I; Rucheton B; Guyonnet-Dupérat V; Cardinaud B; de Verneuil H; Moreau-Gaudry F; Dabernat S
Stem Cells Transl Med; 2017 Feb; 6(2):382-393. PubMed ID: 28191782
[TBL] [Abstract][Full Text] [Related]
5. Technical approaches to induce selective cell death of pluripotent stem cells.
Jeong HC; Cho SJ; Lee MO; Cha HJ
Cell Mol Life Sci; 2017 Jul; 74(14):2601-2611. PubMed ID: 28246701
[TBL] [Abstract][Full Text] [Related]
6. Improving the safety of human pluripotent stem cell therapies using genome-edited orthogonal safeguards.
Martin RM; Fowler JL; Cromer MK; Lesch BJ; Ponce E; Uchida N; Nishimura T; Porteus MH; Loh KM
Nat Commun; 2020 Jun; 11(1):2713. PubMed ID: 32483127
[TBL] [Abstract][Full Text] [Related]
7. The tumorigenicity of diploid and aneuploid human pluripotent stem cells.
Blum B; Benvenisty N
Cell Cycle; 2009 Dec; 8(23):3822-30. PubMed ID: 19887907
[TBL] [Abstract][Full Text] [Related]
8. Ethanol extract of Magnoliae cortex (EEMC) limits teratoma formation of pluripotent stem cells by selective elimination of undifferentiated cells through the p53-dependent mitochondrial apoptotic pathway.
Kim A; Lee SY; Seo CS; Chung SK
Phytomedicine; 2020 Apr; 69():153198. PubMed ID: 32151917
[TBL] [Abstract][Full Text] [Related]
9. Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells.
Go YH; Kim J; Jeong HC; Kim SM; Kim YJ; Park SJ; Moon SH; Cha HJ
Biomedicines; 2020 Oct; 8(11):. PubMed ID: 33121085
[TBL] [Abstract][Full Text] [Related]
10. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.
Tang C; Lee AS; Volkmer JP; Sahoo D; Nag D; Mosley AR; Inlay MA; Ardehali R; Chavez SL; Pera RR; Behr B; Wu JC; Weissman IL; Drukker M
Nat Biotechnol; 2011 Aug; 29(9):829-34. PubMed ID: 21841799
[TBL] [Abstract][Full Text] [Related]
11. Brief Report: External Beam Radiation Therapy for the Treatment of Human Pluripotent Stem Cell-Derived Teratomas.
Lee AS; Tang C; Hong WX; Park S; Bazalova-Carter M; Nelson G; Sanchez-Freire V; Bakerman I; Zhang W; Neofytou E; Connolly AJ; Chan CK; Graves EE; Weissman IL; Nguyen PK; Wu JC
Stem Cells; 2017 Aug; 35(8):1994-2000. PubMed ID: 28600830
[TBL] [Abstract][Full Text] [Related]
12. Laser-assisted photoablation of human pluripotent stem cells from differentiating cultures.
Terstegge S; Winter F; Rath BH; Laufenberg I; Schwarz C; Leinhaas A; Levold F; Dolf A; Haupt S; Koch P; Endl E; Brüstle O
Stem Cell Rev Rep; 2010 Jun; 6(2):260-9. PubMed ID: 20186504
[TBL] [Abstract][Full Text] [Related]
13. Prunellae Spica Extract Suppresses Teratoma Formation of Pluripotent Stem Cells through p53-Mediated Apoptosis.
Kim A; Lee SY; Seo CS; Chung SK
Nutrients; 2020 Mar; 12(3):. PubMed ID: 32182802
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic susceptibility to DNA damage of pluripotent stem cells facilitates pharmacologic purging of teratoma risk.
Smith AJ; Nelson NG; Oommen S; Hartjes KA; Folmes CD; Terzic A; Nelson TJ
Stem Cells Transl Med; 2012 Oct; 1(10):709-18. PubMed ID: 23197662
[TBL] [Abstract][Full Text] [Related]
15. Derivation of pluripotent stem cells from nascent undifferentiated teratoma.
An Y; Sekinaka T; Tando Y; Okamura D; Tanaka K; Ito-Matsuoka Y; Takehara A; Yaegashi N; Matsui Y
Dev Biol; 2019 Feb; 446(1):43-55. PubMed ID: 30529251
[TBL] [Abstract][Full Text] [Related]
16. P53 Regulates Rapid Apoptosis in Human Pluripotent Stem Cells.
Setoguchi K; TeSlaa T; Koehler CM; Teitell MA
J Mol Biol; 2016 Apr; 428(7):1465-75. PubMed ID: 26239243
[TBL] [Abstract][Full Text] [Related]
17. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
[TBL] [Abstract][Full Text] [Related]
18. In vivo surveillance and elimination of teratoma-forming human embryonic stem cells with monoclonal antibody 2448 targeting annexin A2.
Tan HL; Tan BZ; Goh WXT; Cua S; Choo A
Biotechnol Bioeng; 2019 Nov; 116(11):2996-3005. PubMed ID: 31388993
[TBL] [Abstract][Full Text] [Related]
19. The MicroRNA-371 Family as Plasma Biomarkers for Monitoring Undifferentiated and Potentially Malignant Human Pluripotent Stem Cells in Teratoma Assays.
Salvatori DCF; Dorssers LCJ; Gillis AJM; Perretta G; van Agthoven T; Gomes Fernandes M; Stoop H; Prins JB; Oosterhuis JW; Mummery C; Looijenga LHJ
Stem Cell Reports; 2018 Dec; 11(6):1493-1505. PubMed ID: 30503260
[TBL] [Abstract][Full Text] [Related]
20. Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.
Adler-Wailes DC; Kramer JA; DePamphilis ML
Stem Cells Dev; 2017 Feb; 26(4):285-302. PubMed ID: 27821018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
